Forgot Password?

Generic Pharmaceutical Manufacturing in Canada: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Generic Pharmaceutical Manufacturing in Canada Market Research Report | NAICS 32541bCA | Jan 2016

Road to recovery: A new wave of patent expirations is expected to spur industry demand

IBISWorld’s Generic Pharmaceutical Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Industry Statistics & Market Size
Annual Growth 11-16
Annual Growth 16-21
Add to Cart
Add to Cart
Industry Analysis & Industry Trends

After experiencing low export demand and severe pricing pressures over the past five years, the Generic Pharmaceutical Manufacturing industry has significant opportunities to grow in the five years to 2020. A new wave of patent expirations and the growing market for biosimilars are expected to spur demand for new industry products. The industry will likely expand to meet this demand, with new companies increasingly attracted to the industry's new markets and growing profit margins. However, research and development (R&D) costs will continue to limit profit growth and the threat of further provincial reimbursement cuts for generic pharmaceuticals remains high... purchase to read more

Industry Report - Industry Investment Chapter

The average generic pharmaceutical manufacturer in Canada is moderately capital intensive. Drug manufacturing and development requires considerable investment in research and manufacturing equipment, though capital costs are generally less for generics producers than they are for brand-name pharmaceutical manufacturers. In 2016, the Generic Pharmaceutical Manufacturing industry in Canada is expected to spend $0.13 on capital investments for every dollar spent on labour. Acquisition activity has lowered the industry’s capital intensity in recent years, as merged companies can generally realize cost efficiencies and lower capital spending by acquiring existing infrastructure and

eliminating redundancies... purchase to read more


Industry ProductsRelated ReportsTable of Contents

What is the Generic Pharmaceutical Manufacturing Industry?

This industry develops prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

Industry Products
Antineoplastic and immunomodulating agentsCardiovascular system therapiesNervous system therapiesAlimentary tract and metabolic therapiesRespiratory system therapiesOther therapies
Industry Activities
Gaining regulatory approval for generic drugsDeveloping and producing generic drugsMarketing and distributing generic drugs

View Sample
Select Clients